
Erkki Ruoslahti is a Finnish American cancer researcher. Born February 16, 1940, in Puumala. Educated at University of Helsinki. Awards include Knight First Class of the Order of the White Rose of Finland, Canada Gairdner International Award and Robert J. and Claire Pasarow Foundation Award for Distinguished Contributions to Cancer Research.
Facts
20 facts · 1 confirmed by two sources · 7 cited · 12 from one source
Where this comes from
Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.
What Wikidata says · copied November 20, 2026 · revision 2514007619
- Described as
- Finnish American cancer researcher
- Other names
- Erkki I. Ruoslahti, Erkki I Ruoslahti
- Born
- February 16, 1940 · 1 reference
- Born in
- Puumala
- Citizen of
- United States
- Occupation
- physician; university teacher; pharmacologist · 1 reference
- Worked for
- University of California, San Diego; University of California, Santa Barbara · 1 reference; Sanford Burnham Prebys Medical Discovery Institute (1979–2020) · 1 reference
- Education
- University of Helsinki (–1967)
- Member of
- National Academy of Sciences; American Academy of Arts and Sciences
- Awards
- Knight First Class of the Order of the White Rose of Finland (2009) · 1 reference; Canada Gairdner International Award (1997); Robert J. and Claire Pasarow Foundation Award for Distinguished Contributions to Cancer Research (1990) · 1 reference; Japan Prize (2005); Clarivate Citation Laureates (2012) · 1 reference; Albert Lasker Award for Basic Medical Research (2022) · 1 reference; AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research (1990) · 1 reference
- Field
- nanoparticle
- Wikipedias with a page
- 9
Wikidata item Q543772 (wikidata.org/wiki/Q543772), public domain (CC0). Copied November 20, 2026.
What Wikipedia says · copied November 20, 2026 · revision 1385822978
Erkki Ruoslahti (born 16 February 1940) is a Finnish and American cancer researcher. He is a distinguished professor at Sanford Burnham Prebys Medical Discovery Institute. He moved from Finland to the United States in 1976, and he has received U.S. citizenship.
Ruoslahti made seminal contributions to biology of extracellular matrix and its receptors.
He was one of the discoverers of fibronectin, an adhesion molecule and component of extracellular matrices, and he subsequently identified and cloned a number of other extracellular matrix components and adhesion molecules. In 1984, he identified the sequence within fibronectin that mediates cell attachment, called RGD for the amino acids of which it's composed, and isolated the cellular receptors that bind that sequence, now known as integrins. The RGD discovery has led to the development of drugs for vascular thrombosis and cancer, among other diseases.
Ruoslahti currently studies specific marker molecules in blood vessels. He introduced the concept of vascular "zip codes," the idea that each tissue bears molecular signatures that can be targeted by affinity ligands, and used in vivo peptide phage display to prove the concept and develop numerous tumor-homing peptides.
- Born, in its opening lines
- February 16, 1940
From the Wikipedia article “Erkki Ruoslahti” (en.wikipedia.org/wiki/Erkki_Ruoslahti), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied November 20, 2026; not changed.
Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.